MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

Editas Medicine, Inc. (EDIT)

Editas Medicine, Inc. (EDIT)

|||

Balance Sheets Overview

Current Ratio
318.65%
Quick Ratio
318.65%
Cash Ratio
265.68%
Debt to Asset Ratio
55.65%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Marketable securities
    • Right-of-use assets
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Liability for sale of future rev...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
181,815
123,648
146,645
165,648
Marketable securities
29,830
-
0
0
Accounts receivable
2,725
2,592
15,176
8,130
Prepaid expenses and other current assets
3,697
1,826
2,074
3,113
Total current assets
218,067
128,066
163,895
176,891
Property and equipment, net
2,574
2,884
3,542
4,287
Right-of-use assets
13,747
15,412
16,121
17,583
Restricted cash and other non-current assets
2,976
2,976
2,976
2,990
Total assets
237,364
149,338
186,534
201,751
Accounts payable
4,741
4,332
2,605
3,163
Accrued expenses
17,365
21,248
32,610
47,522
Liability for sale of future revenues, current
7,500
7,500
5,000
5,000
Deferred revenue, current
32,315
-
0
0
Operating lease liabilities, current
6,513
6,699
6,031
6,088
Total current liabilities
68,434
39,779
46,246
61,773
Operating lease liabilities, net of current portion
8,998
10,598
12,071
13,564
Liability for sale of future revenues, net of current portion
48,238
47,177
53,605
54,069
Deferred revenue, net of current portion
4,000
44,509
44,509
54,204
Other non-current liabilities
2,413
2,867
2,815
4,688
Total liabilities
132,083
144,930
159,246
188,298
Common stock, 0.0001 par value per share 390,000,000 shares authorized 153,530,898 and 97,866,996 shares issued and outstanding at june30, 2026 and december31, 2025, respectively
15
10
10
9
Additional paid-in capital
1,776,987
1,657,883
1,655,781
1,636,327
Accumulated other comprehensive income (loss)
-6
0
0
0
Accumulated deficit
-1,671,715
-1,653,485
-1,628,503
-1,622,883
Total stockholders equity
105,281
4,408
27,288
13,453
Total liabilities and stockholders equity
237,364
149,338
186,534
201,751
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$181,815K (31.23%↑ Y/Y)Marketable securities$29,830K (-25.35%↓ Y/Y)Prepaid expenses andother current assets$3,697K (-0.27%↓ Y/Y)Accounts receivable$2,725K (363.44%↑ Y/Y)Total current assets$218,067K (19.30%↑ Y/Y)Right-of-use assets$13,747K (-27.69%↓ Y/Y)Restricted cash and othernon-current assets$2,976K (-29.11%↓ Y/Y)Property and equipment,net$2,574K (-43.75%↓ Y/Y)Total assets$237,364K (12.72%↑ Y/Y)Total liabilities andstockholders equity$237,364K (12.72%↑ Y/Y)Total liabilities$132,083K (-30.99%↓ Y/Y)Total stockholdersequity$105,281K (448.65%↑ Y/Y)Accumulated deficit-$1,671,715K (-4.63%↓ Y/Y)Accumulated othercomprehensive income (loss)-$6K (-140.00%↓ Y/Y)Total currentliabilities$68,434K (3.79%↑ Y/Y)Liability for sale offuture revenues, net of...$48,238K (-6.64%↓ Y/Y)Operating leaseliabilities, net of current...$8,998K (-39.97%↓ Y/Y)Deferred revenue, net ofcurrent portion$4,000K (-92.62%↓ Y/Y)Other non-currentliabilities$2,413K (-47.45%↓ Y/Y)Additional paid-in capital$1,776,987K (9.90%↑ Y/Y)Common stock, 0.0001par value per share...$15K (66.67%↑ Y/Y)Deferred revenue,current$32,315K Accrued expenses$17,365K (-63.87%↓ Y/Y)Liability for sale offuture revenues,...$7,500K (50.00%↑ Y/Y)Operating leaseliabilities, current$6,513K (5.97%↑ Y/Y)Accounts payable$4,741K (-29.48%↓ Y/Y)